Anxiety Disorder News and Research

RSS

Comorbid anxiety problematic for adolescents with bipolar disorder

Anxiety disorders are common in children and adolescents with bipolar disorder and adversely affect their outcomes, suggest study findings.

5 Nov 2013

Health anxiety therapies: an interview with Professor Peter Tyrer, Imperial College, London

Health anxiety is a relatively new diagnosis and has not been adopted fully. The nearest approximation and formal classification systems is ‘illness anxiety’ as diagnosed in DSM-5, published in May 2013 (DSM-5, American Psychiatric Association, p.315).

5 Nov 2013

Parental bipolar history common in US bipolar patients

Research findings suggest that patients with bipolar disorder who reside in the United States have a higher parental incidence of bipolar disorder and depression than those who live in Europe.

30 Oct 2013

Obsessive-compulsive disorder and Tourette syndrome are highly heritable

An international research consortium led by investigators at Massachusetts General Hospital (MGH) and the University of Chicago has answered several questions about the genetic background of obsessive-compulsive disorder and Tourette syndrome, providing the first direct confirmation that both are highly heritable and also revealing major differences between the underlying genetic makeup of the disorders.

25 Oct 2013

Multifactorial approach needed for early bipolar detection

At-risk states for bipolar disorder require a multifaceted approach to be identified and appropriately treated, according to preliminary results from the Dresden High-Risk Project.

24 Oct 2013

Pfizer announces top-line results from phase 3b studies with Lyrica Capsules

Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.

19 Oct 2013

CBT more effective in reducing symptoms of health anxiety

Cognitive behavioural therapy (CBT) is substantially more effective than standard care at reducing symptoms of health anxiety in medical patients, and can be delivered by non-specialist staff with minimal training at little extra cost.

19 Oct 2013

UCLA investigates high rates of schizophrenia in people with 22q11.2 deletion syndrome

UCLA has joined an international consortium to investigate the high rates of schizophrenia and other neuropsychiatric disorders in those who are affected with Chromosome 22q11.2 deletion syndrome, a disorder caused by the deletion of a small piece of chromosome number 22.

9 Oct 2013

Publication provides update on the origins and causes of anxiety disorders

Anxiety disorders are not uncommon and are often 'comorbid' with other forms of mental disorders. This publication provides an update on the origins and the causes of anxiety disorders and their related symptoms.

8 Oct 2013

Study: Effect of medication treatments on patients with alcoholism and anxiety

Domenic Ciraulo, MD, chair of psychiatry at Boston University School of Medicine (BUSM) and David H. Barlow, PhD, professor of psychology at Boston University (BU), have collaborated to study the effect of behavioral and medication treatments on patients with alcoholism and anxiety.

8 Oct 2013

Comorbid anxiety warns of bipolar psychotherapy need

Comorbid anxiety may flag those patients with bipolar depression who are in particular need of intensive psychotherapy, suggest findings from the Systematic Treatment Enhancement Program for Bipolar Disorder.

3 Oct 2013

Case for targeting perfectionism in patients with bipolar disorder

Anxiety and stress symptoms may mediate the association between perfectionism and depressive symptoms in patients with bipolar disorder in a “transdiagnostic” process, say researchers.

16 Sep 2013

Improved pediatric bipolar screen unveiled

Researchers have developed a screening instrument for detecting bipolar disorder in children and adolescents from the general population.

30 Aug 2013

Overwhelming fear in children may be a sign of separation anxiety disorder

Most children experience some degree of apprehension and excitement as the first day of school approaches, but what does it mean when a child is overcome with fear at the thought of separating from parents and caregivers to go to class? This overwhelming fear may be a sign of separation anxiety disorder, a condition characterized by a school-aged child's extreme fear and nervousness of separating from loved ones.

22 Aug 2013

Adolescents with symptoms of depression also may be at risk for developing anxiety

Some adolescents who suffer with symptoms of depression also may be at risk for developing anxiety, according to a new study of children's mental health.

13 Aug 2013

Assurex Health announces release of new psychiatric pharmacogenomic test panel

Assurex Health today announced the release of GeneSight Psychotropic 2.0, its lead psychiatric pharmacogenomic test panel. This latest GeneSight Psychotropic version has been updated to include four additional medications that now cover a total of 36 of the most commonly prescribed psychotropic medications in the US.

15 Jul 2013

Seven scientists to receive Annual Klerman and Freedman Prizes from Brain & Behavior Research Foundation

Seven young scientists will be recognized by the Brain & Behavior Research Foundation at its presentation of the Annual Klerman and Freedman Prizes on Friday July 26, 2013 at Le Parker Meriden Hotel, New York, NY.

12 Jul 2013

Gang members and violent men are more likely to suffer from mental disorder

Young men who are gang members suffer unprecedented levels of psychiatric illness, placing a heavy burden on mental health services, according to new research led by Queen Mary, University of London.

12 Jul 2013

Brisdelle receives FDA approval to treat hot flashes associated with menopause

The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.

29 Jun 2013

UH receives NIDA grant to study transdiagnostic CBT to address tobacco cessation

According to the Centers for Disease Control and Prevention, tobacco use continues to be the leading preventable cause of death in the U.S. resulting in more than 440,000 premature deaths a year. An additional 25 million smokers will most likely die of a smoking related illness.

27 Jun 2013